Phase II trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma.
Jose A. Karam
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Other Remuneration - Pfizer
Catherine E Devine
No relevant relationships to disclose
Diana L Urbauer
No relevant relationships to disclose
Marisa Lozano
No relevant relationships to disclose
Kamran Ahrar
No relevant relationships to disclose
Pheroze Tamboli
No relevant relationships to disclose
Nizar M. Tannir
Research Funding - Pfizer
Christopher G. Wood
Honoraria - Pfizer
Research Funding - Pfizer
Other Remuneration - Pfizer